000
| 02289nam 2200361za 4500 |
---|
001 | 9.867088 |
---|
003 | CaOODSP |
---|
005 | 20221107162224 |
---|
007 | cr ||||||||||| |
---|
008 | 190115s2002 onc #o f|0| 0 eng d |
---|
040 | |aCaOODSP|beng |
---|
041 | |aeng|bfre |
---|
043 | |an-cn--- |
---|
086 | 1 |aEn13-5/02-334E-PDF |
---|
245 | 00|aAssessment and management of pharmaceuticals and personal care products in the Canadian environment |h[electronic resource] : |bproceedings of a multi-stakeholder workshop / |cedited by M. R. Servos ... [et al.]. |
---|
246 | 11|aÉvaluation et gestion des produits pharmaceutiques et des produits d'hygiène et de beauté dans I'environnement canadien : |bcompte rendu d'un atelier à intervenants multiples |
---|
260 | |aBurlington, Ont. : |bEnvironment Canada, |c2002. |
---|
300 | |axiii, 68 p. |
---|
490 | 1 |aNWRI contribution ; |vno. 02-334 |
---|
500 | |aDigitized edition from print [produced by Environment and Climate Change Canada]. |
---|
500 | |a"Hosted by / Organisé par Environment Canada and Health Canada, Environnement Canada et Santé Canada, Queen's Landing Inn, Niagara-on-the-Lake, February 24-27, 2002, du 24 au 27 février 2002." |
---|
504 | |aIncludes bibliographic references. |
---|
520 | |a"Traditionally, pharmaceuticals and personal care products have not been viewed as environmental pollutants. However, the potential for these substances to cause a variety of physiological responses in non-target species, has raised concerns for possible impacts on the environment. Although these substances are usually found in very low concentrations in the environment, continuous low dose exposure, especially to sensitive life stages, to these complex mixtures may have significant effects on individuals, populations or ecosystems"--Introduction. |
---|
546 | |aExecutive summaries in French and English. |
---|
692 | 07|2gccst|aDrugs |
---|
692 | 07|2gccst|aPersonal care products |
---|
692 | 07|2gccst|aPollution |
---|
700 | 1 |aServos, M. R. |
---|
710 | 1 |aCanada. |bEnvironment Canada. |
---|
710 | 2 |aNational Water Research Institute (Canada) |
---|
830 | #0|aNWRI contribution ;|vno. 02-334.|w(CaOODSP)9.844121 |
---|
856 | 40|qPDF|s4.10 MB|uhttps://publications.gc.ca/collections/collection_2019/eccc/En13-5-02-334-eng.pdf |
---|